Minimal Residual Disease Clinical Trials in Beijing, Beijing Municipality
4 recruitingBeijing, Beijing Municipality, China
Showing 1–4 of 4 trials
Recruiting
To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)
Neoadjuvant TherapyLung NeoplasmsMinimal Residual Disease+1 more
Peking University People's Hospital100 enrolled1 locationNCT07291921
Recruiting
Not Applicable
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
Non-small Cell Lung CancerMinimal Residual DiseaseAdaptive Treatment
Peking University People's Hospital1,000 enrolled1 locationNCT06930807
Recruiting
Phase 2
VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
Minimal Residual DiseaseMyelodysplastic SyndromesRefractory Acute Myeloid Leukemia+1 more
Beijing 302 Hospital67 enrolled1 locationNCT06536959
Recruiting
Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
Minimal Residual DiseaseGastrointestinal Stromal Tumors
Peking University People's Hospital45 enrolled1 locationNCT05408897